LAWRENCEVILLE, NJ--(Marketwire - Apr 30, 2012) - Celsion Corporation (NASDAQ: [ CLSN ]), a leading oncology drug development company, today announced that Michael H. Tardugno, Celsion's President and Chief Executive Officer, will be presenting at the 37^th Annual Deutsche Bank Health Care Conference on Monday, May 7^th at 1:30 PM Eastern Time at the InterContinental Hotel in Boston, Massachusetts.

A live webcast of the presentation will be available on Celsion's website at [ http://www.celsion.com/events.cfm ]. The webcast will be archived on the same site for replay following the conference.

About Celsion

Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated liposomal drug technology. Celsion has research, license, or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, the UCLA Department of Medicine, Kyungpook National University Hospital and the Beijing Cancer Hospital.

For more information on Celsion, visit our website: [ http://www.celsion.com ].